PLATELET ALPHA(2)-ADRENERGIC RECEPTOR-BINDING AND THE EFFECTS OF D-AMPHETAMINE IN BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

被引:6
|
作者
SHEKIM, WO
BYLUND, DB
HODGES, K
GLASER, R
RAYPRENGER, C
OETTING, G
机构
[1] UNIV NEBRASKA, MED CTR, DEPT PHARMACOL, LINCOLN, NE USA
[2] UNIV MISSOURI, DEPT PHARMACOL & PSYCHIAT, COLUMBIA, MO USA
关键词
ALPHA(2)-ADRENERGIC RECEPTOR; D-AMPHETAMINE; HYPERACTIVITY; NOREPINEPHRINE;
D O I
10.1159/000119074
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Presynaptic inhibitory alpha-adrenergic receptors are involved in regulating the release of norepinephrine (NE) through a negative feedback mechanism mediated by NE. Increased alpha(2)-adrenergic receptor activity suggests decrease NE release and activity, while decreased alpha(2)-adrenergic activity suggests increase NE release and activity. A large body of evidence suggests the involvement of a disturbance in NE activity in the pathophysiology of attention deficit hyperactivity disorder (ADHD) in childhood. Platelet alpha(2)-adrenergic receptor binding was compared in 23 boys aged 7-12 with the diagnosis of ADHD and 11 normal controls. The ADHD boys tended to have lower levels of alpha(2)-binding than controls. The administration of d-amphetamine in a double-blind placebo-controlled crossover design did not have any effect on alpha(2)-receptor binding in ADHD boys. Nonresponders to d-amphetamine had the lowest alpha(2)-receptor binding compared to responders and controls. These findings suggest a normal alpha(2)-adrenergic activity in ADHD boys responders to d-amphetamine and a possible increase in NE release in ADHD boys nonresponders to d-amphetamine due to decreased alpha(2)-adrenergic receptors.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 50 条
  • [1] In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children
    Liang, Hong
    Chen, Jianping
    Miao, Maohua
    Christensen, Jakob
    Dalsgaard, Soren
    Yuan, Wei
    Li, Jiong
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2017, 26 (07) : 847 - 856
  • [2] The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder
    Arnsten, Amy F. T.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (10) : 1595 - 1605
  • [3] Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder
    Szobot, C
    Roman, T
    Cunha, R
    Acton, P
    Hutz, M
    Rohde, LA
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 132B (01) : 53 - 58
  • [4] Emotion Recognition Pattern in Adolescent Boys with Attention-Deficit/Hyperactivity Disorder
    Aspan, Nikoletta
    Bozsik, Csilla
    Gadoros, Julia
    Nagy, Peter
    Inantsy-Pap, Judit
    Vida, Peter
    Halasz, Jozsef
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [5] Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder
    Gorman, Erin B.
    Klorman, Rafael
    Thatcher, Joan E.
    Borgstedt, Agneta D.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (07): : 808 - 816
  • [6] SELF-CONTROL IN BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER - EFFECTS OF ADDED STIMULATION AND TIME
    SCHWEITZER, JB
    SULZERAZAROFF, B
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES, 1995, 36 (04): : 671 - 686
  • [7] Neurofunctional Effects of Methylphenidate and Atomoxetine in Boys with Attention-Deficit/Hyperactivity Disorder During Time Discrimination
    Smith, Anna
    Cubillo, Ana
    Barrett, Nadia
    Giampietro, Vincent
    Simmons, Andrew
    Brammer, Mick
    Rubia, Katya
    BIOLOGICAL PSYCHIATRY, 2013, 74 (08) : 615 - 622
  • [8] Attention-deficit hyperactivity disorder and the adrenergic receptors α1C and α2C
    C L Barr
    K Wigg
    G Zai
    W Roberts
    M Malone
    R Schachar
    R Tannock
    J L Kennedy
    Molecular Psychiatry, 2001, 6 : 334 - 337
  • [9] Attention-deficit hyperactivity disorder and the adrenergic receptors α1C and α2C
    Barr, CL
    Wigg, K
    Zai, G
    Roberts, W
    Malone, M
    Schachar, R
    Tannock, R
    Kennedy, JL
    MOLECULAR PSYCHIATRY, 2001, 6 (03) : 334 - 337
  • [10] Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder
    Danielle C. Turner
    Andrew D. Blackwell
    Jonathan H. Dowson
    Andrew McLean
    Barbara J. Sahakian
    Psychopharmacology, 2005, 178 : 286 - 295